Clinical activity of enzalutamide (Enza) pre- and post-docetaxel in men with metastatic castration-resistant prostate cancer (mCRPC).
Rosa Nadal
No relevant relationships to disclose
Zhe Zhang
No relevant relationships to disclose
Hitesh Raheja
No relevant relationships to disclose
Mario A. Eisenberger
No relevant relationships to disclose
Emmanuel S. Antonarakis
No relevant relationships to disclose